CCL5 and asthma: A previous study showed that MAP3K19, a component of the MAPK pathway, suppressed allergic airway inflammation in asthma models by modulating epithelial response to stimuli such as TWEAK and TGFβ1, thereby reducing the production of pro-inflammatory cytokines such as RANTES (CCL5) [164].